Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program.

Area of Science:

• Pharmaceutical Sciences
• Drug Compounding
• Patient Safety

Background:

• Particulates in sterile injectable preparations present significant patient safety risks.
• While direct human studies are limited, particles can cause embolic events and granulomas by blocking blood vessels.
• Achieving particle-free injectable preparations is practically impossible in real-world compounding settings.

Purpose of the Study:

• To outline regulatory expectations for visual inspection of compounded sterile injectables.
• To detail requirements for a robust visual inspector training and qualification program.
• To describe adequate visual inspection procedures and equipment for compounded drug products.

Main Methods:

• Review of regulatory guidelines and standards for sterile compounding.
• Analysis of common findings and noncompliance observations related to particulate matter.
• Description of essential elements for effective visual inspection protocols.

Main Results:

• Visual inspection is a mandatory step to mitigate risks associated with particulate matter.
• Effective inspection requires well-trained and qualified personnel.
• Appropriate procedures and equipment are crucial for reliable particulate detection.

Conclusions:

• Implementing stringent visual inspection protocols is critical for ensuring the safety of compounded sterile injectable drugs.
• Adherence to regulatory expectations for inspection, training, and equipment minimizes patient risk.
• Proactive measures in visual inspection are necessary to prevent dispensing non-compliant and potentially harmful drug products.